Wearable Devices Secures $750,000 Grant for Clinical Pilot Program
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 11 2025
0mins
Should l Buy WLDS?
Source: Newsfilter
- Funding Support: Wearable Devices has received a $750,000 grant approval from the Israel Innovation Authority for a clinical pilot program in partnership with Soroka University Medical Center, aimed at validating the Mudra Link neural wristband as a rehabilitation tool, thereby expanding the company's market presence in medical technology.
- Technology Application: The pilot will utilize patented surface neural ElectroMyography (EMG) technology to provide real-time, objective biofeedback to help patients improve grip-force control, marking a broader applicability of Mudra technology in neural interaction and enhancing the competitiveness of the company's products.
- Market Potential: The Mudra platform is designed for low-cost rehabilitation therapy that can be performed at home with minimal therapist supervision, which not only meets the demand for efficient rehabilitation solutions but also positions it to potentially establish itself as the standard of care in grip-force neurorehabilitation worldwide.
- Clinical Validation: By collaborating with Soroka Hospital, Wearable Devices is advancing clinical validation, aiming to leverage Mudra Link's ability to capture objective neuro-muscular data, thus enhancing treatment accessibility and accelerating recovery for patients with complex neurological motor deficits.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WLDS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WLDS
About WLDS
Wearable Devices Ltd is an Israel-based company. Wearable Devices Ltd is primarily engaged in developing a non-invasive neural input interface technology for business-to-business (B2B) and business-to-customer (B2C) customers. Company's products are non-invasive neural input interface closed in the form of a wristband to allow control of other digital devices with natural subtle hand finger movements and fingertip pressure. Company's technology is used in digital devices such as, consumer electronics, smart watches, smartphones, Augmented Reality (AR) glasses, Virtual Reality (VR) headsets, televisions, personal computers (PCs), laptop , drones, robots. Company's product portfolio includes Mudra Band and Mudra Inspire.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wearable Devices Partners with Rokid for Gesture-Controlled AI Glasses Bundle
- Partnership Announcement: Wearable Devices' new partnership with Rokid aims to integrate the Mudra Link gesture band with Rokid's AI and AR glasses for natural touchless control, with joint marketing planned for Q2 2026, although the stock has pulled back after an initial rally.
- Product Integration: Both companies will align efforts on product readiness and go-to-market strategy to ensure intuitive gesture control for end users, with expectations that Mudra Link and Rokid Glasses will pair quickly and easily out of the box.
- Consumer Rollout Plans: The combined product bundle is projected for general release in mid-2026, with the first public demonstrations scheduled for CES 2026 in Las Vegas from January 6-9, where Wearable Devices and Rokid will showcase their innovations at separate booths.
- Market Outlook: Despite a current stock decline of 5.39% to $1.29, CEO Asher Dahan emphasized the demand for effortless control devices, suggesting that this collaboration will enhance user engagement with AI features without interruption or frustration.
See More
Wearable Devices Partners with Rokid to Launch Gesture-Controlled Glasses
- Collaborative Innovation: Wearable Devices collaborates with Rokid to launch compatible Mudra Link and Rokid Glasses, with a consumer bundle rollout planned for Q2 2026, aimed at enhancing user experience and simplifying operational processes.
- Market Promotion: Both companies will jointly market the seamless pairing of Mudra Link with Rokid Glasses, enhancing consumer convenience in daily use, which is expected to drive product sales growth.
- Technology Demonstration: The two companies will showcase their combined experience at CES 2026, with Wearable Devices at LVCC Central Hall Booth 15650 and Rokid at Booth 17214, attracting media and analyst attention.
- Industry Outlook: As smart glasses become mainstream, the gesture control feature of Mudra Link will provide users with a more natural interaction method, expected to drive broader applications of AR and AI technologies, enhancing market competitiveness.
See More
Wearable Devices Secures $750,000 Grant for Clinical Pilot Program
- Funding Support: Wearable Devices has received a $750,000 grant approval from the Israel Innovation Authority for a clinical pilot program in partnership with Soroka University Medical Center, aimed at validating the Mudra Link neural wristband as a rehabilitation tool, thereby expanding the company's market presence in medical technology.
- Technology Application: The pilot will utilize patented surface neural ElectroMyography (EMG) technology to provide real-time, objective biofeedback to help patients improve grip-force control, marking a broader applicability of Mudra technology in neural interaction and enhancing the competitiveness of the company's products.
- Market Potential: The Mudra platform is designed for low-cost rehabilitation therapy that can be performed at home with minimal therapist supervision, which not only meets the demand for efficient rehabilitation solutions but also positions it to potentially establish itself as the standard of care in grip-force neurorehabilitation worldwide.
- Clinical Validation: By collaborating with Soroka Hospital, Wearable Devices is advancing clinical validation, aiming to leverage Mudra Link's ability to capture objective neuro-muscular data, thus enhancing treatment accessibility and accelerating recovery for patients with complex neurological motor deficits.
See More
Wearable Devices Enters Warrant Inducement Agreement for 3.32M Shares at $1.71 Each
- Financing Agreement Reached: Wearable Devices has signed a warrant inducement agreement with an existing institutional investor for the immediate exercise of 3.32 million warrants, expected to generate approximately $5.68 million in cash proceeds, enhancing the company's working capital for operational and corporate purposes.
- New Warrants Issued: As part of the agreement, the company will issue 5.81 million new warrants to the investor at an exercise price of $1.86 per share, which will be exercisable upon shareholder approval, thereby improving the company's capital structure and financing flexibility.
- Transaction Timeline: The warrant inducement transaction is expected to close around December 1, 2025, subject to customary closing conditions, providing essential funding support for the company's future business development.
- Market Positioning Strengthened: This financing will enable Wearable Devices to accelerate innovation in the AI and wearable device sectors, further solidifying its competitive position in the rapidly evolving technology market.
See More
Wearable Devices Enters Warrant Inducement Agreement for Immediate Exercise of 3.32M Warrants
- Financing Agreement Reached: Wearable Devices has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of 3.32 million warrants, expected to generate approximately $5.68 million in cash proceeds, thereby enhancing the company's liquidity to support working capital and other corporate needs.
- New Warrant Issuance: The company will issue 5.81 million new warrants to the investor at an exercise price of $1.86 per share, which will become exercisable upon shareholder approval, further strengthening the capital structure and providing flexibility for future financing.
- Transaction Timeline: The warrant inducement transaction is expected to close around December 1, 2025, subject to customary closing conditions, ensuring timely access to funds to support the company's operational plans.
- Market Compliance: This transaction relies on an exemption under Section 4(a)(2) of the Securities Act of 1933, ensuring compliance for the newly issued securities in the U.S. market, thereby reducing potential legal risks and enhancing investor confidence.
See More
Wearable Devices Raises $5.68M via Warrant Inducement Agreement with Institutional Investor
Warrant Inducement Agreement: Wearable Devices has entered into a warrant inducement agreement with an institutional investor for the immediate exercise of warrants to purchase 3,322,000 ordinary shares at $1.71 each, generating approximately $5.68 million in gross proceeds.
Use of Proceeds: The company plans to utilize the net proceeds from this transaction for working capital and other general corporate purposes.
Stock Performance: Following the announcement, Wearable Devices' stock has increased by 4.84% in premarket trading, reaching a price of $1.95.
Recent Offerings: The company has also recently announced a pricing of a $3.3 million direct offering and private placement.
See More
Wearable Devices Partners with Rokid for Gesture-Controlled AI Glasses Bundle
- Partnership Announcement: Wearable Devices' new partnership with Rokid aims to integrate the Mudra Link gesture band with Rokid's AI and AR glasses for natural touchless control, with joint marketing planned for Q2 2026, although the stock has pulled back after an initial rally.
- Product Integration: Both companies will align efforts on product readiness and go-to-market strategy to ensure intuitive gesture control for end users, with expectations that Mudra Link and Rokid Glasses will pair quickly and easily out of the box.
- Consumer Rollout Plans: The combined product bundle is projected for general release in mid-2026, with the first public demonstrations scheduled for CES 2026 in Las Vegas from January 6-9, where Wearable Devices and Rokid will showcase their innovations at separate booths.
- Market Outlook: Despite a current stock decline of 5.39% to $1.29, CEO Asher Dahan emphasized the demand for effortless control devices, suggesting that this collaboration will enhance user engagement with AI features without interruption or frustration.
See More
Wearable Devices Partners with Rokid to Launch Gesture-Controlled Glasses
- Collaborative Innovation: Wearable Devices collaborates with Rokid to launch compatible Mudra Link and Rokid Glasses, with a consumer bundle rollout planned for Q2 2026, aimed at enhancing user experience and simplifying operational processes.
- Market Promotion: Both companies will jointly market the seamless pairing of Mudra Link with Rokid Glasses, enhancing consumer convenience in daily use, which is expected to drive product sales growth.
- Technology Demonstration: The two companies will showcase their combined experience at CES 2026, with Wearable Devices at LVCC Central Hall Booth 15650 and Rokid at Booth 17214, attracting media and analyst attention.
- Industry Outlook: As smart glasses become mainstream, the gesture control feature of Mudra Link will provide users with a more natural interaction method, expected to drive broader applications of AR and AI technologies, enhancing market competitiveness.
See More
Wearable Devices Secures $750,000 Grant for Clinical Pilot Program
- Funding Support: Wearable Devices has received a $750,000 grant approval from the Israel Innovation Authority for a clinical pilot program in partnership with Soroka University Medical Center, aimed at validating the Mudra Link neural wristband as a rehabilitation tool, thereby expanding the company's market presence in medical technology.
- Technology Application: The pilot will utilize patented surface neural ElectroMyography (EMG) technology to provide real-time, objective biofeedback to help patients improve grip-force control, marking a broader applicability of Mudra technology in neural interaction and enhancing the competitiveness of the company's products.
- Market Potential: The Mudra platform is designed for low-cost rehabilitation therapy that can be performed at home with minimal therapist supervision, which not only meets the demand for efficient rehabilitation solutions but also positions it to potentially establish itself as the standard of care in grip-force neurorehabilitation worldwide.
- Clinical Validation: By collaborating with Soroka Hospital, Wearable Devices is advancing clinical validation, aiming to leverage Mudra Link's ability to capture objective neuro-muscular data, thus enhancing treatment accessibility and accelerating recovery for patients with complex neurological motor deficits.
See More
Wearable Devices Enters Warrant Inducement Agreement for 3.32M Shares at $1.71 Each
- Financing Agreement Reached: Wearable Devices has signed a warrant inducement agreement with an existing institutional investor for the immediate exercise of 3.32 million warrants, expected to generate approximately $5.68 million in cash proceeds, enhancing the company's working capital for operational and corporate purposes.
- New Warrants Issued: As part of the agreement, the company will issue 5.81 million new warrants to the investor at an exercise price of $1.86 per share, which will be exercisable upon shareholder approval, thereby improving the company's capital structure and financing flexibility.
- Transaction Timeline: The warrant inducement transaction is expected to close around December 1, 2025, subject to customary closing conditions, providing essential funding support for the company's future business development.
- Market Positioning Strengthened: This financing will enable Wearable Devices to accelerate innovation in the AI and wearable device sectors, further solidifying its competitive position in the rapidly evolving technology market.
See More
Wearable Devices Enters Warrant Inducement Agreement for Immediate Exercise of 3.32M Warrants
- Financing Agreement Reached: Wearable Devices has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of 3.32 million warrants, expected to generate approximately $5.68 million in cash proceeds, thereby enhancing the company's liquidity to support working capital and other corporate needs.
- New Warrant Issuance: The company will issue 5.81 million new warrants to the investor at an exercise price of $1.86 per share, which will become exercisable upon shareholder approval, further strengthening the capital structure and providing flexibility for future financing.
- Transaction Timeline: The warrant inducement transaction is expected to close around December 1, 2025, subject to customary closing conditions, ensuring timely access to funds to support the company's operational plans.
- Market Compliance: This transaction relies on an exemption under Section 4(a)(2) of the Securities Act of 1933, ensuring compliance for the newly issued securities in the U.S. market, thereby reducing potential legal risks and enhancing investor confidence.
See More
Wearable Devices Raises $5.68M via Warrant Inducement Agreement with Institutional Investor
Warrant Inducement Agreement: Wearable Devices has entered into a warrant inducement agreement with an institutional investor for the immediate exercise of warrants to purchase 3,322,000 ordinary shares at $1.71 each, generating approximately $5.68 million in gross proceeds.
Use of Proceeds: The company plans to utilize the net proceeds from this transaction for working capital and other general corporate purposes.
Stock Performance: Following the announcement, Wearable Devices' stock has increased by 4.84% in premarket trading, reaching a price of $1.95.
Recent Offerings: The company has also recently announced a pricing of a $3.3 million direct offering and private placement.
See More
